Youmin Wang
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Thyroid Disorders and Treatments 3
- Co-authors
- Nina Liu (3 shared papers)Datong Deng (8 shared papers)Quan Liu (1 shared paper)Loyd V Allen (2 shared papers)Qiu Zhang (3 shared papers)Jianlong Sheng (2 shared papers)Mingwei Chen (8 shared papers)Min Xu (6 shared papers)
- Journals
- International Wound Journal (2 papers)Pharmaceutical Development and Technology (2 papers)Medicine (1 paper)International Journal of Pharmaceutics (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Youmin Wang
44 papers receiving 462 citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 60
- Endocrinology, Diabetes and Metabolism 71
- Rehabilitation 25
- Cancer Research 56
- Epidemiology 82
Countries citing papers authored by Youmin Wang
This map shows the geographic impact of Youmin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youmin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youmin Wang more than expected).
Fields of papers citing papers by Youmin Wang
This network shows the impact of papers produced by Youmin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youmin Wang. The network helps show where Youmin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Youmin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 66 | |
| 2 | 2012 | 36 | |
| 3 | 2019 | 25 | |
| 4 | 1993 | 24 | |
| 5 | Calorie control increased vaspin levels of serum and periepididymal adipose tissue in diet-induced obese rats in association with serum free fatty acid and tumor necrosis factor alpha. | 2010 | 23 |
| 6 | 2002 | 22 | |
| 7 | 2009 | 21 | |
| 8 | 1999 | 20 | |
| 9 | 2014 | 20 | |
| 10 | 2018 | 19 | |
| 11 | 2012 | 15 | |
| 12 | 2022 | 14 | |
| 13 | 2022 | 14 | |
| 14 | Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model. | 2015 | 13 |
| 15 | 2010 | 11 | |
| 16 | 2000 | 11 | |
| 17 | 2019 | 10 | |
| 18 | 2017 | 9 | |
| 19 | 2005 | 9 | |
| 20 | 2013 | 9 |
About Youmin Wang
Youmin Wang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Epidemiology, Pharmaceutical Science and Genetics, having authored 45 papers that have together received 473 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Optical Imaging and Spectroscopy Techniques (3 papers), Adipose Tissue and Metabolism (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Photoacoustic and Ultrasonic Imaging (3 papers), Thyroid Disorders and Treatments (3 papers), Advancements in Transdermal Drug Delivery (3 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Pharmaceutical Science (60 citations), Endocrinology, Diabetes and Metabolism (71 citations), Rehabilitation (25 citations), Cancer Research (56 citations) and Epidemiology (82 citations). Youmin Wang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Nina Liu, Datong Deng, Quan Liu, Loyd V Allen, Qiu Zhang, Jianlong Sheng, Mingwei Chen, Min Xu, Tianrong Pan and Soumitra Ghosh. Their work appears in journals such as International Wound Journal, Pharmaceutical Development and Technology, Medicine, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.